Charme Capital Partners has become the new majority investor in Prism Healthcare, a company specializing in medical devices for disabled and mobility-impaired individuals.
Charme Capital will support Prism Healthcare's growth both organically and through acquisitions, both in the UK and internationally.
Under the ownership and leadership of Limerston Capital, Prism Healthcare has established itself as a market leader in the home care and long-term care sectors. Prism Healthcare's product portfolio includes patient lifts, bathing systems, specialty seating and standing aids, and other products designed for disabled and mobility-impaired individuals. These products help patients remain mobile and active in their homes, long-term care facilities, or acute care environments.
Over the past three years, Prism Healthcare has doubled its turnover, successfully completing several acquisitions, including Assured, CareAbility, and Harvest Healthcare, while expanding its range of services and products. Prism employs over 650 people across nine UK locations and has a network of international distributors operating in the EU, US, and other global markets.
Charme Capital will support Prism Healthcare's future expansion plans, including investments in IT and manufacturing, and will drive growth through further acquisitions both in the UK and internationally.
Charme Capital Partners is a European mid-market private equity fund that helps management teams and shareholders achieve transformative change, growth, and internationalization. With offices in Milan, London, and Madrid, Charme Capital invests in companies across Europe with enterprise values ranging from €100 million to €500 million. Charme Capital Partners has acquired Prism Healthcare through its Charme IV fund.
Limerston Capital is a London-based private equity firm managing over GBP 300 million in assets. Limerston focuses on companies valued between GBP 50 and 200 million. The existing investor in Prism Healthcare, Limerston, will remain invested in the company alongside the management team.
ConAlliance is a leading M&A advisory firm specializing in comprehensive support for company sales and acquisitions within the healthcare sector. Since its founding in 2011, ConAlliance has successfully managed over 150 mandates.
ConAlliance's expertise is highly focused on corporate transactions within the healthcare sector. In addition to the hospital industry and manufacturers of hospital equipment, ConAlliance's core competencies include pharmaceuticals, nursing, healthcare IT, medical technology, medical devices, and other manufacturing and service companies in the global healthcare industry, as well as healthcare real estate.
For more information about ConAlliance, please visit www.ConAlliance.com.